Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44

被引:56
作者
Hershkovitz, Oren
Jivov, Sergey
Bloushtain, Noga
Zilka, Alon
Landau, Guy
Bar-Ilan, Ahuva
Lichtenstein, Rachel G.
Campbell, Kerry S.
van Kuppevelt, Toin H.
Porgador, Angel [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel
[4] Radboud Univ Nijmegen Med Ctr, Dept Biochem, NCMLS, Nijmegen, Netherlands
[5] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA
关键词
HEPARAN-SULFATE PROTEOGLYCANS; VIRUS-INFECTED CELLS; HUMAN NK RECEPTORS; MEDIATED CYTOLYSIS; KILLER-CELLS; ACTIVATION; MELANOMA; BINDING; CANCER; NKP30;
D O I
10.1021/bi7000455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NKp44 is a natural cytotoxicity receptor expressed by human NK cells upon activation. In this study, we demonstrate that cell surface heparan sulfate proteoglycans (HSPGs), expressed by target cells, are involved in the recognition of tumor cells by NKp44. NKp44 showed heparan sulfate-dependent binding to tumor cells; this binding was partially blocked with an antibody to heparan sulfate. In addition, direct binding of NKp44 to heparin was observed, and soluble heparin/heparan sulfate enhanced the secretion of IFN gamma by NK92 cells activated with anti-NKp44 monoclonal antibody. Basic amino acids, predicted to constitute the putative heparin/heparan sulfate binding site of NKp44, were mutated. Tumor cell recognition of the mutated NKp44 proteins was significantly reduced and correlated with their lower recognition of heparin. We previously reported that NKp44 recognizes the hemagglutinin of influenza virus (IV). Nevertheless, the ability of the mutated NKp44 proteins to bind viral hemagglutinin expressed by IV-infected cells was not affected. Thus, we suggest that heparan sulfate epitope(s) are ligands/co-ligands of NKp44 and are involved in its tumor recognition ability.
引用
收藏
页码:7426 / 7436
页数:11
相关论文
共 40 条
[21]   Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor [J].
Garg, Ankita ;
Barnes, Peter F. ;
Porgador, Angel ;
Roy, Sugata ;
Wu, Shiping ;
Nanda, Jagpreet S. ;
Griffith, David E. ;
Girard, William M. ;
Rawal, Nenoo ;
Shetty, Sreerama ;
Vankayalapati, Ramakrishna .
JOURNAL OF IMMUNOLOGY, 2006, 177 (09) :6192-6198
[22]   Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro [J].
Jayson, GC ;
Lyon, M ;
Paraskeva, C ;
Turnbull, JE ;
Deakin, JA ;
Gallagher, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :51-57
[23]   Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells [J].
Kleeff, J ;
Wildi, S ;
Kumbasar, A ;
Friess, H ;
Lander, AD ;
Korc, M .
PANCREAS, 1999, 19 (03) :281-288
[24]   IN SEARCH OF THE MISSING SELF - MHC MOLECULES AND NK CELL RECOGNITION [J].
LJUNGGREN, HG ;
KARRE, K .
IMMUNOLOGY TODAY, 1990, 11 (07) :237-244
[25]   NKp46 [J].
Mandelboim, O ;
Porgador, A .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (12) :1147-1150
[26]   Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells [J].
Mandelboim, O ;
Lieberman, N ;
Lev, M ;
Paul, L ;
Arnon, TI ;
Bushkin, Y ;
Davis, DM ;
Strominger, JL ;
Yewdell, JW ;
Porgador, A .
NATURE, 2001, 409 (6823) :1055-1060
[27]   Variable receptors controlling activation and inhibition of NK cells [J].
McQueen, KL ;
Parham, P .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (05) :615-621
[28]   Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis [J].
Moretta, A ;
Bottino, C ;
Vitale, M ;
Pende, D ;
Cantoni, C ;
Mingari, MC ;
Biassoni, R ;
Moretta, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :197-223
[29]   Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis [J].
Moretta, A ;
Biassoni, R ;
Bottino, C ;
Mingari, MC ;
Moretta, L .
IMMUNOLOGY TODAY, 2000, 21 (05) :228-234
[30]   Different checkpoints in human NK-cell activation [J].
Moretta, L ;
Bottino, C ;
Pende, D ;
Vitale, M ;
Mingari, MC ;
Moretta, A .
TRENDS IN IMMUNOLOGY, 2004, 25 (12) :670-676